Select from our A to Z index of CMI (Consumer Medicines Information) leaflets for both prescription and over-the-counter medicines. Available as HTML, PDF and large font PDF.
Imiglucerase-rch 200 U and 400 U, Powder for Injection
Consumer Medicine Information
This leaflet answers some common questions about Cerezyme®.
It does not contain all the available information.
It does not take the place of talking to your doctor or a trained health care professional.
All medicines have risks and benefits. Your doctor has weighed the risks of you or your child having Cerezyme® against the benefits they expect it will have.
If you have any concerns about this medicine, ask your doctor or nurse.
Keep this leaflet. You may need to read it again.
Cerezyme® is used as enzyme replacement therapy in Type I Gaucher disease, a disease in which the enzyme beta-glucocerebrosidase in the body does not work properly.
Patients with Gaucher disease do not produce enough of their own active enzyme, beta-glucocerebrosidase. The reduced beta-glucocerebrosidase activity in patients results in the accumulation of a fatty substance in the body called glucocerebroside. Cerezyme® is an enzyme replacement therapy that is intended to restore a level of.enzyme activity enough to remove the built up glucocerebroside and to prevent further build up.
Do not take Cerezyme® if you or your child have a known, severe, life-threatening allergic reaction to:
Symptoms of an allergic reaction may include:
If you are not sure whether you or your child should have Cerezyme®, talk to your doctor or nurse.
Tell your doctor if you or your child have reacted to previous treatments with any of the following:
Tell your doctor if you or your child have allergies to:
Tell your doctor if you are pregnant or intend to become pregnant. There is no information available regarding the use of Cerezyme® in pregnant women. Your doctor will discuss the possible risks and benefits of having Cerezyme® during pregnancy.
Tell your doctor if you are breast-feeding. It is not known whether Cerezyme® passes into breast milk. Your doctor will discuss the possible risks and benefits of having Cerezyme® during breast-feeding.
Tell your doctor or nurse if you or your child are taking any other medicines, including any that you buy without a prescription from your pharmacy, supermarket or health food shop.
Some medicines and Cerezyme® may interfere with each other. No studies have been carried out on drug interactions.
Cerezyme® will be given to you or your child directly into the vein (intravenously) in a hospital, in a clinic or in your home..
Your doctor will decide on the dose and frequency of infusion that is most suitable.
There have been no reported overdoses of Cerezyme®.
Keep appointments with your doctor or clinic. It is important to have the infusion with Cerezyme® at the appropriate times to make sure the medicine has the best chance of providing effective treatment for the condition.
Have any tests when your doctor says to. Your doctor may wish to test your or your child's body's response to Cerezyme® to make sure that it is working.
Be careful driving or operating machinery until you know how Cerezyme® affects you. Cerezyme is unlikely to have any effect on your ability to drive a car or operate machinery. Make sure that you know how you react to Cerezyme® before you drive a car or operate machinery or do anything else that may be dangerous if you are dizzy, light-headed, tired or drowsy.
Tell your doctor or nurse as soon as possible if you or your child do not feel well after having Cerezyme®. Cerezyme® may have unwanted side effects in a few people. All medicines can have side effects. Sometimes they are serious, but most of the time they are not. You or your child may need urgent medical treatment if you notice some side effects.
Ask your doctor or nurse to answer any questions you may have.
Tell your doctor or pharmacist if you notice any of the following:
Cerezyme® will usually be stored in the hospital or clinic pharmacy..
However, if you are storing Cerezyme® at home before it has has been prepared for infusion, place it in the refrigerator (2°C - 8°C) but do not freeze it.
If you are storing Cerezyme® at home after it has has been prepared for infusion, place it in the refrigerator (2°C - 8°C) but do not freeze it. It is important that Cerezyme® that has been prepared for infusion is used within 24hours.
If you notice particles in the solution that has been made for you at the hospital, do not infuse and contact your doctor or pharmacist immediately.
Cerezyme® is a white to off-white powder before it is prepared for infusion and a clear, colourless solution after it has been prepared for infusion.
Active ingredient: Imiglucerase-rch
Other ingredients: sodium citrate dihydrate, mannitol, citric acid monohydrate, polysorbate 80 and Haemaccel®.
In Australia this product is registered by:
Genzyme Australasia Pty Ltd
Suite 2.02, 21 Solent Crt
Baulkham Hills NSW 2153
Phone: +61 2 8852 3900
AUST R 68331 and 74277
In New Zealand this product is registered by:
Medra Services Limited
PO Box 115
Fielding
New Zealand
Cerezyme® is a registered trademark of Genzyme Corporation, USA.
This leaflet was prepared on 24 Aug 2004
CZM ANZ CMI A0408-01
Published by MIMS/myDr October 2005